Endothelial cell surface

The endothelial cell surface is the critical interface between the circulating blood or lymph and the vessel wall, serving as a gatekeeper for molecular and cellular exchange (Pober & Sessa, 2007, Nature Reviews Immunology). It consists of a complex layer of membrane proteins and the endothelial glycocalyx, which regulates vascular permeability, inflammation, and coagulation (Reitsma et al., 2007, Pflugers Archiv). While not a single molecular entity, the surface expresses numerous specific targets such as VEGF receptors and adhesion molecules (ICAM-1, VCAM-1) that are central to the pathogenesis of cancer, atherosclerosis, and sepsis (Aird, 2007, Blood). In disease states, the endothelial surface becomes activated, leading to increased leukocyte recruitment and altered signaling (Hunt & Jurd, 1998, Cardiovascular Research). Because it is directly exposed to the bloodstream, this surface is a primary site for therapeutic intervention and targeted drug delivery systems (Aird, 2004, Journal of Thrombosis and Haemostasis).

Other names

Vascular endotheliumEndothelial luminal surfaceEndothelial glycocalyxVascular interface

Drugs targeting the endothelial cell surface typically act by binding to specific receptors (e.g., VEGFR), inhibiting adhesion molecules (e.g., integrins), or protecting the glycocalyx to restore vascular barrier function and reduce inflammation (Aird, 2007, Blood; Reitsma et al., 2007, Pflugers Archiv).